top of page

Korro Bio CEO on RNA editing and the process behind reverse mergers

Ram Aiyar discusses RNA editing and the news announced Friday that his company Korro Bio is aiming to do a reverse merge to go public.



Comentarios


Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page